Kai Riecke

823 total citations
30 papers, 653 citations indexed

About

Kai Riecke is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Kai Riecke has authored 30 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 7 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Kai Riecke's work include Iron Metabolism and Disorders (6 papers), Animal testing and alternatives (5 papers) and Immunotoxicology and immune responses (4 papers). Kai Riecke is often cited by papers focused on Iron Metabolism and Disorders (6 papers), Animal testing and alternatives (5 papers) and Immunotoxicology and immune responses (4 papers). Kai Riecke collaborates with scholars based in Germany, Netherlands and Austria. Kai Riecke's co-authors include Ralf Stahlmann, S Vauléon, Luciana Summo, Frank Schwoebel, Dorine W. Swinkels, Stefan Zöllner, Mehdi Shakibaei, Malcolm Boyce, Steve Warrington and Peter Ulrich and has published in prestigious journals such as Blood, Cancer Research and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Kai Riecke

30 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Riecke Germany 13 174 165 127 121 102 30 653
A Ueki Japan 17 97 0.6× 233 1.4× 195 1.5× 40 0.3× 21 0.2× 33 770
Hongxia Yan China 17 127 0.7× 392 2.4× 113 0.9× 147 1.2× 21 0.2× 47 768
Maria Rita Bongiorno Italy 14 39 0.2× 120 0.7× 124 1.0× 32 0.3× 189 1.9× 70 674
MT Esselink Netherlands 15 145 0.8× 181 1.1× 277 2.2× 73 0.6× 39 0.4× 34 689
Carole Ferraro France 5 106 0.6× 160 1.0× 157 1.2× 42 0.3× 23 0.2× 5 510
M Lecha Spain 20 23 0.1× 397 2.4× 182 1.4× 20 0.2× 458 4.5× 64 1.4k
Steven J. Glassman Canada 13 43 0.2× 91 0.6× 151 1.2× 28 0.2× 320 3.1× 37 680
Toshitaro Nakagawa Japan 16 225 1.3× 306 1.9× 172 1.4× 51 0.4× 23 0.2× 33 706
B.C. Hakkert Netherlands 10 140 0.8× 142 0.9× 273 2.1× 10 0.1× 11 0.1× 21 656
Adele R. Vessey United States 11 148 0.9× 127 0.8× 284 2.2× 9 0.1× 52 0.5× 13 638

Countries citing papers authored by Kai Riecke

Since Specialization
Citations

This map shows the geographic impact of Kai Riecke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Riecke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Riecke more than expected).

Fields of papers citing papers by Kai Riecke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Riecke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Riecke. The network helps show where Kai Riecke may publish in the future.

Co-authorship network of co-authors of Kai Riecke

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Riecke. A scholar is included among the top collaborators of Kai Riecke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Riecke. Kai Riecke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Steurer, Michael, Marco Montillo, Lydia Scarfò, et al.. (2019). Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia. Haematologica. 104(10). 2053–2060. 69 indexed citations
3.
Ludwig, Heinz, Katja Weisel, Maria Teresa Petrucci, et al.. (2017). Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib–dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study. Leukemia. 31(4). 997–1000. 60 indexed citations
4.
Macdougall, Iain C., et al.. (2015). FP660PHARMACOKINETICS AND PHARMACODYNAMICS OF LEXAPTEPID, A NOVEL ANTI-HEPCIDIN MOLECULE, IN ESA-RESISTANT HAEMODIALYSIS PATIENTS. Nephrology Dialysis Transplantation. 30(suppl_3). iii294–iii295. 7 indexed citations
5.
6.
Eijk, Lucas T. van, Frank Schwoebel, Luciana Summo, et al.. (2014). Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans. Blood. 124(17). 2643–2646. 79 indexed citations
7.
Gobbi, Marco, Michael Steurer, Federico Caligaris‐Cappio, et al.. (2013). Anti-CXCL12/SDF-1 Spiegelmer® Nox-A12 Alone and In Combination With Bendamustine and Rituximab In Patients With Relapsed Chronic Lymphocytic Leukemia (CLL): Results From A Phase IIa Study. Blood. 122(21). 1635–1635. 8 indexed citations
8.
9.
Ludwig, Heinz, Katja Weisel, Monika Engelhardt, et al.. (2013). Anti-CXCL12/SDF-1 Spiegelmer® Nox-A12 Alone and In Combination With Bortezomib and Dexamethasone In Patients With Relapsed Multiple Myeloma: Results From A Phase IIa Study. Blood. 122(21). 1951–1951. 6 indexed citations
10.
11.
Stahlmann, Ralf, et al.. (2006). Sensitising potential of four textile dyes and some of their metabolites in a modified local lymph node assay. Toxicology. 219(1-3). 113–123. 35 indexed citations
12.
Hecht, Monica, Armin Gamer, Henk Van Loveren, et al.. (2005). An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay. Toxicology. 212(1). 69–79. 53 indexed citations
13.
Hecht, Monica, Armin Gamer, Henk Van Loveren, et al.. (2005). An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay: First round. Toxicology. 212(1). 60–68. 43 indexed citations
14.
Riecke, Kai, André Schmidt, & Ralf Stahlmann. (2003). Effects of 2,3,7,8-TCDD and PCB 126 on human thymic epithelial cells in vitro. Archives of Toxicology. 77(6). 358–364. 10 indexed citations
15.
Riecke, Kai, Daniela Grimm, Mehdi Shakibaei, et al.. (2002). Low doses of 2,3,7,8-tetrachlorodibenzo- p -dioxin increase transforming growth factor β and cause myocardial fibrosis in marmosets ( Callithrix jacchus ). Archives of Toxicology. 76(5-6). 360–366. 41 indexed citations
16.
Stahlmann, Ralf & Kai Riecke. (2001). Unerwünschte Wirkungen der Chinolone: Gut verträglich oder risikoreich?. Pharmazie in unserer Zeit. 30(5). 412–417. 4 indexed citations
17.
Riecke, Kai, Ana Cristina Martins de Almeida Nogueira, Vladimir Alexi‐Meskishvili, & Ralf Stahlmann. (2000). Cross‐reactivity of antibodies on thymic epithelial cells from humans and marmosets by flow‐cytometry. Journal of Medical Primatology. 29(5). 343–349. 7 indexed citations
18.
Riecke, Kai & Ralf Stahlmann. (2000). Test systems to identify reproductive toxicants. Andrologia. 32(4-5). 209–218. 8 indexed citations
19.
Riecke, Kai, Thomas Schulz, Mehdi Shakibaei, et al.. (2000). Developmental toxicity of the HIV-protease inhibitor indinavir in rats. Teratology. 62(5). 291–300. 13 indexed citations
20.
Riecke, Kai, et al.. (1997). [Pulmonary melioidosis in a German Southeast Asia tourist].. PubMed. 51(5). 499–502. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Ueki Breakdown of academic impact, for papers by Hongxia Yan Breakdown of academic impact, for papers by Maria Rita Bongiorno Breakdown of academic impact, for papers by MT Esselink Breakdown of academic impact, for papers by Carole Ferraro Breakdown of academic impact, for papers by M Lecha Breakdown of academic impact, for papers by Steven J. Glassman Breakdown of academic impact, for papers by Toshitaro Nakagawa Breakdown of academic impact, for papers by B.C. Hakkert Breakdown of academic impact, for papers by Adele R. Vessey
Rankless by CCL
2026